date:Sep 16, 2013
e condition specific nutraceutical market.
According to Dr. Rudi E. Moerck, President and CEO of Valensa, the algae technology relationship with Algaeon provides a significant additional supplier of algae biomass and extracts to Valensa to allow the company to grow its portfolio of advanced condition specific products. Valensa is a rapidly growing nutraceutical company with a thriving astaxanthin-based, condition-specific formulation business, said Moerck. We are excited and confident that this